Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Other Proteins

Human B4GALT1 Recombinant Protein (C-Fc) (HC014011)

Human B4GALT1 Recombinant Protein (C-Fc)
Human B4GALT1 Recombinant Protein (C-Fc)
Price(USD):
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HC014011
Description
Recombinant Human B4GALT1 Protein, C-Fc (HC014011) expressed in Mammalian Cells, spanning Arg45-Ser398.
Highlights
  • Fc Fusion — Enhanced stability with Protein A/G purification compatibility.
  • Mammalian Expression — Proper folding and native glycosylation.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemMammalian cells
AccessionP15291
Protein lengthArg45-Ser398
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesHomo sapiens (Human)
Nature Recombinant
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Predicted molecular weight 65.70 kDa
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesBeta-14-galactosyltransferase 1, Beta-14-GalTase 1, Beta4Gal-T1, b4Gal-T1, EC:2.4.1.-, Beta-N-acetylglucosaminyl-glycolipid beta-14-galactosyltransferase, Beta-N-acetylglucosaminylglycopeptide beta-14-galactosyltransferase, EC:2.4.1.38, Lactose synthase A protein, EC:2.4.1.22, N-acetyllactosamine synthase, EC:2.4.1.90, Nal synthase, Neolactotriaosylceramide beta-14-galactosyltransferase, EC:2.4.1.275, UDP-Gal:beta-GlcNAc beta-14-galactosyltransferase 1, UDP-galactose:beta-N-acetylglucosamine beta-14-galactosyltransferase 1, Processed beta-14-galactosyltransferase 1, B4GALT1, GGTB2
Background

Beta-1,4-galactosyltransferase 1 is a ~43 kDa protein. Galactosyltransferase acting in the Golgi stacks. Catalyzes the transfer of galactose (Gal) from UDP-alpha-D-galactose in beta(1->4) linkage to the non-reducing terminal N-acetylglucosamine (GlcNAc) moieties of glycolipids and complex-type N-linked glycans. Adds one Gal residue to both GlcNAc beta(1->2)-linked to the alpha(1->3) and alpha(1->6) mannose antennae of complex-type N-glycans, enabling the formation of mono- and di-galactosylated glycoforms. Galactosylates complex-type N-glycans attached on the fragment crystallizable (Fc) of immunoglobulin-gamma isotypes (IgGs), a prerequisite for antibody glycan sialylation and related anti-inflammatory effector functions. Can also transfer a Gal residue to free GlcNAc to form N-acetyllactosamine.

1. Ramasamy, V. et al. (2005) Journal of molecular biology 353, 53-67. PMID: 16157350
2. Dekkers, G. et al. (2016) Scientific reports 6, 36964. PMID: 27872474
3. Benedetti, E. et al. (2017) Nature communications 8, 1483. PMID: 29133956
4. Jaroentomeechai, T. et al. (2022) Nature communications 13, 6325. PMID: 36280670
5. Ma, W. et al. (2023) Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10, e2303832. PMID: 37632720
6. Makrydaki, E. et al. (2024) Nature chemical biology 20, 732-741. PMID: 38321209
Note For research use only
Images
  • Human B4GALT1 Recombinant Protein (C-Fc)

    SDS-PAGE

    SDS-PAGE for Recombinant Human B4GALT1 Protein, C-Fc

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list